Pfizer and BioNTech began the formal process of seeking FDA clearance for a Covid-19 booster shot, submitting data showing a third vaccine dose generated higher levels of neutralizing antibodies against the original virus and its Beta and Delta variants
Pfizer Inc. and partner BioNTech SE have submitted data to U.S. health regulators needed to clearThe companies said Monday they sent to the U.S.
Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general populationPfizer and BioNTech said they have submitted early-stage clinical trial data to the FDA as part of their application seeking U.S. OK of a Covid booster shot.
Weiterlesen »
Pfizer submits initial data for COVID-19 vaccine booster authorizationIn the trial, the third dose elicited significantly higher neutralizing antibodies against the initial SARS-CoV-2 virus compared to the levels observed after the two-dose primary series, as well as against the highly infectious Delta variant.
Weiterlesen »
Turkey Offers Additional Pfizer-BioNTech Shots Amid Concern Over Chinese VaccineAnkara said it would allow people who got Chinese-made Covid-19 shots to be fully revaccinated with Pfizer and BioNTech doses to help ease travel to countries that haven’t approved the Sinovac vaccine.
Weiterlesen »
Australia purchases Pfizer vaccines from Poland as COVID-19 infections spikeAustralia has purchased about 1 million doses of Pfizer Inc's (PFE.N) COVID-19 vaccine from Poland to add to its inoculation efforts in Sydney and its home state, which on Saturday entered a snap lockdown amid record new infections.
Weiterlesen »
Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general populationPfizer and BioNTech said they have submitted early-stage clinical trial data to the FDA as part of their application seeking U.S. OK of a Covid booster shot.
Weiterlesen »
Pfizer submits initial data for COVID-19 vaccine booster authorizationIn the trial, the third dose elicited significantly higher neutralizing antibodies against the initial SARS-CoV-2 virus compared to the levels observed after the two-dose primary series, as well as against the highly infectious Delta variant.
Weiterlesen »